[
  {
    "id": 1,
    "name": "Haloperidol",
    "type": "First generation anti-psychotics",
    "route": "IM, PO",
    "dose": {
      "IM": "5 mg - 10 mg",
      "PO": "5 mg - 30 mg / day"
    },
    "half-life": {
      "IM": "20 hours",
      "PO": "14 - 36 hours"
    },
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 2,
    "name": "Chlopromazine",
    "type": "First generation anti-psychotics",
    "route": "PO",
    "dose": {
      "IM": "5 mg - 10 mg",
      "PO": "5 mg - 30 mg / day"
    },
    "half-life": "14 - 36 hours",
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 3,
    "name": "Fluphenazine",
    "type": "First generation anti-psychotics",
    "route": "IM",
    "dose": "20 mg - 80 mg",
    "half-life": "2 - 3 weeks (LAI)",
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 4,
    "name": "Zuclopenthixol",
    "type": "LAI First generation anti-psychotics",
    "route": "IM",
    "dose": "IM": "200 mg - 400 mg / 2 - 4 weeks",
    "half-life": "2 - 4 weeks",
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 5,
    "name": "Flupenthixol",
    "type": "LAI First generation anti-psychotics",
    "route": "IM (LAI)",
    "dose": "5 mg - 10 mg",
    "half-life": "4 weeks (LAI)",
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 6,
    "name": "Risperidone",
    "type": "Second generation anti-psychotics",
    "route": "PO",
    "dose": "2 mg - 8 mg / day",
    "half-life": "14 - 36 hours",
    "pharmacodynamics": "5HT2A blockade at lower doses, and high potency D2 receptor binding at higher doses",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia, Weight gain",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 7,
    "name": "Olanzapine",
    "type": "Second generation anti-psychotics",
    "route": "PO",
    "dose": "5 mg - 20 mg / day",
    "half-life": "14 - 36 hours",
    "pharmacodynamics": "5HT2A blocker and D2 blocker",
    "side effects": "Metabolic syndrome, Weight gain",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 8,
    "name": "Quetiapine",
    "type": "Second generation anti-psychotics",
    "route": "PO",
    "dose": "50 mg - 400 mg / day",
    "half-life": "14 - 36 hours",
    "pharmacodynamics": "5HT2A blocker and D2 receptor binding",
    "side effects": "Sedation, Prolonged QT interval",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 9,
    "name": "Aripiprazole",
    "type": "Second generation anti-psychotics",
    "route": "PO",
    "dose": "5 mg - 10 mg / day",
    "half-life": "14 - 36 hours",
    "pharmacodynamics": "D2 receptor partial agonist",
    "side effects": "Akathisia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 10,
    "name": "Paliperidone",
    "type": "Second generation anti-psychotics",
    "route": "IM (LAI)",
    "dose": "100 mg / monthly (LAI)",
    "half-life": "1 - 3 months",
    "pharmacodynamics": "5HT2A receptor blocker and D2 receptor blocker",
    "side effects": "Akathisia, Extrapyridal syndrome",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 11,
    "name": "Clozapine",
    "type": "First generation anti-psychotics",
    "route": "PO",
    "dose": "100 mg - 800 mg / day",
    "half-life": "14 - 36 hours",
    "pharmacodynamics": "Anti-histamine, anticholinergic and D4 receptor blockade",
    "side effects": "Agranulocytosis, Seizures, Myocarditis, Constipation",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 12,
    "name": "Haloperidol",
    "type": "First generation anti-psychotics",
    "route": "IM, PO",
    "dose": "",
    "half-life": "",
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
  {
    "id": 13,
    "name": "Haloperidol",
    "type": "First generation anti-psychotics",
    "route": "IM, PO",
    "dose": "",
    "half-life": "",
    "pharmacodynamics": "Potent D2 receptor binding",
    "side effects": "Acute dystonia, Pseudoparkinsonism, Tardive Dyskinesia",
    "url": "https://g6.psychcentral.com/drugs/wp-content/uploads/2016/03/haloperidol.jpg"
  },
]
